| OVID THERAPEUTICS DL-,001 |
| USA |
| Gesundheit |
| US6904691010 / A2DQ8S |
| 1OT (Frankfurt) / OVID (NASDAQ) |
| FRA:1OT, ETR:1OT, 1OT:GR, NASDAQ:OVID |
| - |
| https://ovidrx.com/ |
|
Ovid Therapeutics Inc. is a biopharmaceutical company dedicated to developing transformative medicines for rare neurological disorders. Its primary focus is on creating innovative therapies for patien..
>Volltext.. |
| 219.95 Mio. EUR |
| 209.9 Mio. EUR |
| 5.73 Mio. EUR |
| -35.06 Mio. EUR |
| -31.48 Mio. EUR |
| -0.44 EUR |
| 11.92 Mio. EUR |
| 17.86 Mio. EUR |
| -32.87 Mio. EUR |
| 3.77 |
| 893.07% |
| -6.06% |
| - |
| - |
| - |
| - |
| OVID THERAPEUTICS, OVID THERAPEUTIC, OVID THERA |
| 18.03.26 |
|